Lumenis Selecta Duet SLT/YAG Laser Gen1

Refurbished Lumenis Selecta Duet SLT/YAG Laser Gen1 –
Dual-Function Ophthalmic Laser for Glaucoma & Capsulotomy
The refurbished Lumenis Selecta Duet SLT/YAG Laser Gen1 is a
high-performance ophthalmic laser system that
integrates Selective Laser Trabeculoplasty (SLT) and YAG laser capabilities in a single,
efficient device. Designed to provide precise, safe, and effective treatments,
the Selecta Duet is ideal for glaucoma management and
posterior capsulotomy procedures. With its proven technology and
reliable performance, this system remains a
trusted choice among ophthalmologists looking for a cost-effective,
dual-mode laser solution.

Key Features & Benefits:
Dual-Mode Functionality – Supports SLT for open-angle glaucoma and
YAG laser procedures such as posterior capsulotomy and iridotomy, all in one device.

Non-Thermal SLT Technology – Uses low-energy selective photothermolysis to
target melanin-rich trabecular meshwork cells without collateral damage,
ensuring safe and repeatable treatments.

Adjustable Energy Settings – Allows customization for different patient needs,
optimizing safety and efficacy.

User-Friendly Interface & Ergonomic Design – Intuitive joystick controls and
a seamless slit lamp interface improve workflow and treatment efficiency.

Reliable & Cost-Effective Solution – Refurbished to OEM standards,
ensuring top-tier performance and longevity at a fraction of the cost of a new system.

The Lumenis Selecta Duet Gen 1 remains a trusted,
industry-proven dual-mode laser system that provides exceptional precision and
reliability for ophthalmic laser treatments.
Whether you need a non-invasive SLT solution for glaucoma management or
a high-precision YAG laser for capsulotomy and iridotomy,
the Selecta Duet offers the versatility and efficiency required in a
modern ophthalmic practice.

Purchasing a refurbished Selecta Duet Gen 1 allows you to
acquire advanced laser technology at a significantly reduced price,
while maintaining the same level of precision and treatment effectiveness as a new unit.